Abstract
Targeted nanoparticulated drug delivery systems have gained much attention owing to their potential in elevating anti-tumor effect and decreasing drug-originated side effects. In this contribution, a kind of dual glioma targeting delivery system was developed through co-modification nanoparticles with interlukin-13 peptide (IL-13p) and RGD peptide (IRNPs), in which IL-13p could target to IL13Rα2 on tumor cells and RGD could target to αvβ3 on neovasculature. The model drug, docetaxel (DTX), could release from the unmodified nanoparticles (NPs) and IRNPs at a sustained manner. In vitro, the uptake of IRNPs by C6 (a glioma cell line) cells was time- and concentration-dependent, which was significantly higher than the uptake of NPs and single modified nanoparticles. After loading with DTX, IRNPs induced the highest percentage of apoptotic cells. In vivo, DTX-loaded IRNPs induced obviously higher apoptosis of cells in glioma site. These results indicated the dual modification could improve the cellular uptake as well as antitumor effect, which demonstrated IRNPs were promising drug delivery systems for glioma targeting treatment.
Keywords: Dual targeting, glioma, interleukin 13 peptide, nanoparticles, RGD.
Current Pharmaceutical Biotechnology
Title:Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles
Volume: 14 Issue: 13
Author(s): Huile Gao, Yue Hu, Yang Xiong, Shuang Zhang, Jiarong Yang, Lian Yu and Xinguo Jiang
Affiliation:
Keywords: Dual targeting, glioma, interleukin 13 peptide, nanoparticles, RGD.
Abstract: Targeted nanoparticulated drug delivery systems have gained much attention owing to their potential in elevating anti-tumor effect and decreasing drug-originated side effects. In this contribution, a kind of dual glioma targeting delivery system was developed through co-modification nanoparticles with interlukin-13 peptide (IL-13p) and RGD peptide (IRNPs), in which IL-13p could target to IL13Rα2 on tumor cells and RGD could target to αvβ3 on neovasculature. The model drug, docetaxel (DTX), could release from the unmodified nanoparticles (NPs) and IRNPs at a sustained manner. In vitro, the uptake of IRNPs by C6 (a glioma cell line) cells was time- and concentration-dependent, which was significantly higher than the uptake of NPs and single modified nanoparticles. After loading with DTX, IRNPs induced the highest percentage of apoptotic cells. In vivo, DTX-loaded IRNPs induced obviously higher apoptosis of cells in glioma site. These results indicated the dual modification could improve the cellular uptake as well as antitumor effect, which demonstrated IRNPs were promising drug delivery systems for glioma targeting treatment.
Export Options
About this article
Cite this article as:
Gao Huile, Hu Yue, Xiong Yang, Zhang Shuang, Yang Jiarong, Yu Lian and Jiang Xinguo, Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles, Current Pharmaceutical Biotechnology 2013; 14 (13) . https://dx.doi.org/10.2174/1389201015666140425102937
DOI https://dx.doi.org/10.2174/1389201015666140425102937 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Multi-Modal Imaging and Cancer Therapy Using Lanthanide Oxide Nanoparticles: Current Status and Perspectives
Current Medicinal Chemistry Melatonin Receptor as a Drug Target for Neuroprotection
Current Molecular Pharmacology Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Current Medicinal Chemistry Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Application of Mesenchymal Stem Cells in the Targeted Gene Therapy for Gastric Cancer
Current Stem Cell Research & Therapy The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix
Anti-Cancer Agents in Medicinal Chemistry Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Anti-Cancer Agents in Medicinal Chemistry Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Current Neuropharmacology Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators
Anti-Cancer Agents in Medicinal Chemistry Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Anticancer Active Heterocyclic Chalcones: Recent Developments
Anti-Cancer Agents in Medicinal Chemistry An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
Current Cancer Drug Targets The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets STAT3 as a Central Regulator of Tumor Metastases
Current Molecular Medicine Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology